The FDA has approved popular antiobesity drug Ozempic to help protect patients with type 2 diabetes from kidney disease.

KDIGO guideline is the first specifically addressing autosomal dominant polycystic kidney disease (ADPKD) and focuses on some unique aspects of management.

The FDA’s approval of Ozempic to battle chronic kidney disease “allows us to more broadly address conditions within cardiovascular-kidney-metabolic syndrome, which affects millions of ...

The FDA has approved Ozempic (semaglutide) to reduce the risk of kidney disease worsening and cardiovascular death in those with T2D and CKD.

Heart disease is closely linked with obesity. Excess weight mainly accounts for the surge in deaths from cardiovascular ...

According to the National Kidney Foundation, 123,000 Americans are on that waitlist. More than a 100,000 of those waiting ...

Adults with diabetes, heart disease, heart failure, hypertension, or kidney failure may ignore dietary restrictions due to exposure to foods advertised during sporting events.

Sixteen-year-old Colette Nwachukwu is appealing for financial assistance to undergo surgery after being diagnosed with advanced ...

The WHO released a set of guidelines on Sunday recommending the use of lower-sodium salt substitutes, essentially including ...

This week the World Health Organization (WHO) released new guidelines recommending people switch the regular salt they use at ...

HNN Investigates has learned each year up to nearly half of the kidneys donated in the islands wind up going to patients ...